<--- Back to Details
First PageDocument Content
Technology / Good manufacturing practice / Form FDA 483 / Center for Devices and Radiological Health / Medical device / Design controls / Quality management system / QSIT / Title 21 of the Code of Federal Regulations / Food and Drug Administration / Medicine / Health
Technology
Good manufacturing practice
Form FDA 483
Center for Devices and Radiological Health
Medical device
Design controls
Quality management system
QSIT
Title 21 of the Code of Federal Regulations
Food and Drug Administration
Medicine
Health

Microsoft Word - 1- CP[removed]Coversheet February[removed]Final.doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 623,47 KB

Share Document on Facebook

Similar Documents

Jeffrey Shuren, M.D., J.D. Director Center for Devices and Radiological Health Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MD

DocID: 1tLOR - View Document

Digital Health Innovation Action Plan  Introduction FDA’s Center for Devices and Radiological Health (CDRH) puts patients at the forefront of our vision—we are driven by timely patient access to high-quality, s

DocID: 1ttzz - View Document

Post-doctoral fellow position #2 – Research Focus Nanotechnology/nanotoxicology - Safety of engineered nanomaterials The Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryl

DocID: 1sM2j - View Document

Sunlamps: Regulatory Issues W. Howard Cyr, Ph.D. Office of Science and Technology, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD USA For distribution at the following meetings:

DocID: 1srEV - View Document

Food and Drug Administration / Health / Food law / Pharmaceuticals policy / Personal life / Pharmaceutical industry / Healthcare quality / Federal Food /  Drug /  and Cosmetic Act / Medical device / Validation / Center for Devices and Radiological Health / RNA-Seq

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document